Search for: "Watson Laboratories Inc" Results 21 - 40 of 143
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Nov 2016, 8:23 pm by Kate Howard
Watson Laboratories, Inc. 16-493 Issue: Whether the “on sale” bar found in Section 102(b) of the Patent Act applies only to sales or offers of sale made available to the public, as Congress, this court, and the United States have all made clear, or whether it also applies to non-public sales or offers of sale, as the U.S. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
10 Oct 2016, 4:00 am by Karim Benyekhlef and Nicolas Vermeys
We are reminded of the wise words written by Justice Mahoney in Apple Computer, Inc. v. [read post]
8 Jul 2016, 2:54 am
In Thermo LabSystems [TTABlogged here], the TTAB found WATSON to be primarily a surname for laboratory management software. [read post]
16 May 2016, 9:59 pm by Patent Docs
Watson Laboratories, Inc., ANDA litigation over claim 4 of U.S. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The FTC’s complaint alleges that Endo engaged in a pay for delay scheme by paying the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
11 Apr 2016, 2:32 pm by Robert Reznick
  The FTC’s complaint attacks two such settlements that Endo Pharmaceuticals Inc. and the Japan-based patent holder for one of the relevant patents reached with generic manufacturers Watson Laboratories (and Watson’s current owner, Allergan plc) and Impax Laboratories, to settle Hatch-Waxman litigation involving Endo’s two most important products—the pain relievers Opana ER® and Lidoderm®.[2]  The FTC’s… [read post]
1 Apr 2016, 5:30 am by Gene Quinn
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
1 Apr 2016, 5:30 am by Gene Quinn
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
11 Nov 2015, 4:51 am
In this patent infringement action, Watson Laboratories, Inc.'s ("Watson") moved to dismiss several counts of the complaint filed by Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, "Jazz"). [read post]
4 Oct 2015, 9:08 pm by Patent Docs
Watson Laboratories, Inc. 3:15-cv-05723; filed July 22, 2015 in the District Court of New Jersey Infringement of U.S. [read post]
13 Sep 2015, 9:21 pm by Patent Docs
• Defendants: Watson Laboratories, Inc.; Actavis, Inc.; Actavis Pharma, Inc. [read post]